Patents Assigned to GENIX THERAPEUTICS GROUP, LLC
  • Treatment of huntington'S disease
    Patent number: 9408865
    Abstract: The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: August 9, 2016
    Assignee: Genix Therapeutics Group, LLC
    Inventor: Ragab El-Rashidy
  • Treatment of Huntington's disease
    Patent number: 8889125
    Abstract: The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 18, 2014
    Assignee: Genix Therapeutics Group, LLC
    Inventor: Ragab El-Rashidy
  • Treatment of Huntington's Disease
    Publication number: 20140271592
    Abstract: The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: GENIX THERAPEUTICS GROUP, LLC
    Inventor: Ragab El-Rashidy